"Glaxo Said to Be Among Three Bidders for Turkey’s Biofarma
By Ercan Ersoy - Apr 7, 2011 9:27 AM GMT+0300
GlaxoSmithKline Plc (GSK) is among three potential buyers of Turkish drugmaker Biofarma Pharmaceutical Industry Co., two people with knowledge of the matter said.
The other prospective bidders also are multinational companies, the people said yesterday, declining to be identified because the auction isn’t public. A winning bidder may be chosen within two to three months, one of the people said. Biofarma, an Istanbul-based maker of generic drugs, is valued between $600 million and $700 million, the person said. "
More:Glaxo Said to Be Among Three Bidders for Turkey’s Biofarma - Bloomberg
